Viewing Study NCT06090461


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-05-27 @ 4:43 AM
Study NCT ID: NCT06090461
Status: COMPLETED
Last Update Posted: 2025-06-25
First Post: 2023-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)
Sponsor: Currax Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords: